Riskpilot← Back to searchSign inGet full accessMEDIC ADVICE ApS
APSActiveCVR 29193320Hørsholm Kongevej 51Other information service activities · NACE 6392Est. 20051 employees
Revenue 2024
DKK 215K
+31% vs 2023
EBITDA margin
98.2%
+29% vs 2023
Equity ratio
94.9%
Financial strength
Net profit 2024
DKK 226K
+155% vs 2023
| Revenue | DKK 215K | +31% |
| EBITDA | DKK 211K | +29% |
| Net profit | DKK 226K | +155% |
| Total assets | DKK 3,1M | +6% |
| Equity | DKK 2,9M | +4% |
| Employees | 1 | — |
Legal name
MEDIC ADVICE ApS
CVR number
29193320
Legal form
Anpartsselskab
NACE code
6392 · Other information service activities
Founded
25. november 2005
Share capital
DKK 130.000
Employees
1 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Selskabet tegnes af en direktør
Company purpose
Selskabets formål er er at eje eller medeje selskaber med virke indenfor bioteknologi, lægemiddeludvikling og klinisk medicinsk behandling.
Address
Hørsholm Kongevej 51
Phone
+4526373380
Email
mrj@medic-advice.dk
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | -7 | -11 | 297 | 416 | 294 | 325 | 491 | 494 | 201 | 194 | 132 | 163 | 215 |
| Staff expenses | -0 | -0 | -0 | -0 | -0 | -0 | -43 | -101 | -0 | -0 | -0 | -0 | -4 |
| EBITDA | -7 | -11 | 297 | 416 | 294 | 325 | 448 | 393 | 201 | 194 | 132 | 163 | 211 |
| Depreciation & amort. | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 |
| EBIT | -7 | -11 | 297 | 416 | 294 | 325 | 448 | 393 | 201 | 194 | 132 | 163 | 211 |
| Net financials | 384 | 467 | 184 | 722 | -102 | 542 | -88 | 771 | 964 | 3.674 | -2.101 | -573 | 15 |
| Profit before tax | 377 | 456 | 481 | 1.138 | 192 | 867 | 360 | 1.164 | 1.165 | 3.868 | -1.969 | -410 | 226 |
| Tax | 7 | 11 | 120 | 270 | 46 | 192 | 81 | 257 | 262 | 857 | 3 | -0 | -0 |
| Net profit | 371 | 445 | 361 | 868 | 145 | 675 | 279 | 907 | 903 | 3.011 | -1.972 | -410 | 226 |
| Item | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | 1.472 | 2.671 | 2.524 | 3.372 | 3.014 | 3.738 | 3.943 | 4.994 | 5.879 | 6.639 | 4.296 | 2.888 | 3.066 |
| Equity | 1.453 | 1.801 | 2.065 | 2.834 | 2.878 | 3.449 | 3.625 | 4.424 | 5.216 | 5.368 | 3.281 | 2.804 | 2.908 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 19 | 870 | 459 | 538 | 136 | 289 | 318 | 570 | 663 | 1.271 | 1.015 | 84 | 158 |
| Total debt | 19 | 870 | 459 | 538 | 136 | 289 | 318 | 570 | 663 | 1.271 | 1.015 | 84 | 158 |
EBITDA margin
98.2%
This company
15.8%
Market median
+522% vs market
20122024
Equity ratio
94.9%
This company
38.2%
Market median
+148% vs market
20122024
Return on equity
7.8%
This company
18.4%
Market median
-58% vs market
20122024
Net profit margin
105.3%
This company
8.1%
Market median
+1200% vs market
20122024
Asset turnover
0.07×
This company
1.12×
Market median
-94% vs market
20122024
Debt / equity
0.05×
This company
0.62×
Market median
+92% vs market
20122024
- Annual report 2024Filed via CVR / Virk · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via CVR / Virk · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via CVR / Virk · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via CVR / Virk · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via CVR / Virk · Period 2020-01-01 – 2020-12-31
- Annual report 2019Filed via CVR / Virk · Period 2019-01-01 – 2019-12-31
- Annual report 2018Filed via CVR / Virk · Period 2018-01-01 – 2018-12-31
- Annual report 2017Filed via CVR / Virk · Period 2017-01-01 – 2017-12-31
- Annual report 2016Filed via CVR / Virk · Period 2016-01-01 – 2016-12-31
- Annual report 2015Filed via CVR / Virk · Period 2015-01-01 – 2015-12-31
- Annual report 2014Filed via CVR / Virk · Period 2014-01-01 – 2014-12-31
- Annual report 2013Filed via CVR / Virk · Period 2013-01-01 – 2013-12-31
- Annual report 2012Filed via CVR / Virk · Period 2012-01-01 – 2012-12-31
No data on file.
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
| Board of Directors | 2007 | — | — | |
| Chairman | 2007 | — | — |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Individual | 50.0% | 50.0% | 2015 | |
| Individual | 50.0% | 50.0% | 2015 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
MEDIC ADVICE ApS 
Cell to Cure ApSBoard members of MEDIC ADVICE ApS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Steen Lindkær-Jensen | Board of Directors | 0 companies |
| Claus Asbjørn Andersson | Chairman | 0 companies |